GlassScriptPhysician profile
Manan Shah
NPI 1376897645
$2,970.11
in general payments reported to CMS, 2019-2025
24 companies · $231 in 2025
The $231 reported for 2025 was more than what a typical Neurocritical Care provider received nationally (typical 2025 total: $95.82).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $18.79 · 2021: $107 · 2022: $1,746 · 2023: $407 · 2024: $297 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $934.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Uk Limited | $1,621.15 | 2022 | |
| Chiesi USA, INC. | $167.34 | 2022-2025 | Cleviprex |
| Sk Life Science, INC. | $146.23 | 2023-2024 | |
| Stryker Corporation | $145.92 | 2023 | Trevo |
| Takeda Pharmaceuticals U.S.A., INC. | $140.49 | 2021-2025 | Entyvio |
| Ucb, INC. | $138.65 | 2020-2024 | Briviact |
| Jazz Pharmaceuticals INC. | $115.09 | 2022-2025 | |
| Alexion Pharmaceuticals, INC. | $75.96 | 2021-2024 | Soliris, Ultomiris |
| Pfizer INC. | $58.81 | 2019-2023 | |
| Csl Behring | $47.93 | 2019 | |
| Genentech USA, INC. | $41.19 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.52 | 2019 | |
| Biogen, INC. | $29.13 | 2025 | Spinraza |
| Amgen INC. | $27.67 | 2024 | |
| Azurity Pharmaceuticals, INC. | $24.35 | 2025 | Nymalize |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $23.16 | 2024 | Iheezo |
| Greenwich Biosciences, INC. | $22.53 | 2021 | |
| Ceribell, INC. | $20.00 | 2025 | Pocket Eeg Device |
| Olympus America INC. | $19.94 | 2024 | Evis Exera III Colonovideoscope |
| Novartis Pharmaceuticals Corporation | $16.93 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.66 | 2021 | |
| Medtronic, INC. | $15.92 | 2023 | Kyphon Express II Kyphopak Tray |
| Natus Medical Incorporated | $11.05 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manan Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.